Moreover, high SPOCK1 expression was associated with lower tumor mutational burden (TMB) and homologous recombination deficiency (HRD) scores, indicating that SPOCK1 may influence DNA repair capacity and tumor heterogeneity, ultimately contributing to treatment resistance and metastatic potential. The gene discussed is SPOCK1; the disease is neoplasm.